_PRIVATE_LIMITED.webp)
Aceprobe Technologies (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 283.35%
- Profit Growth 846.99%
- Ebitda 181.73%
- Net Worth 42.48%
- Total Assets 280.57%
About Aceprobe Technologies (India)
Aceprobe Technologies (India) Private Limited (ATIPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 April 2009 and has a history of 15 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Puneet Chandna and Bindia Chandna serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900DL2009PTC189137
-
Company No.
189137
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Apr 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aceprobe Technologies (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Chandna
|
Director | 22-Jun-2009 | Current |
|
Bindia Chandna
|
Director | 22-Jun-2009 | Current |
Financial Performance of Aceprobe Technologies (India).
Aceprobe Technologies (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 283.35% increase. The company also saw a substantial improvement in profitability, with a 846.99% increase in profit. The company's net worth Soared by an impressive increase of 42.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aceprobe Technologies (India)?
Unlock access to Aceprobe Technologies (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aceprobe Technologies (India)?
Unlock and access historical data on people associated with Aceprobe Technologies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aceprobe Technologies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aceprobe Technologies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
